Inflammatory markers response to citrulline supplementation in patients with non-alcoholic fatty liver disease: a randomized, double blind, placebo-controlled, clinical trial

OBJECTIVES: The aim of this study was to investigate the effects of citrulline (Cit) supplementation on inflammatory markers and liver histopathology in patients with non-alcoholic fatty liver disease (NAFLD). In this clinical trial, fifty NAFLD patients were assigned to receive 2 g/day Cit or place...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:BMC Res Notes
Egile Nagusiak: Darabi, Zahra, Darand, Mina, Yari, Zahra, Hedayati, Mehdi, Faghihi, Amirhosein, Agah, Shahram, Hekmatdoost, Azita
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BioMed Central 2019
Gaiak:
Research Note
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6376741/
https://ncbi.nlm.nih.gov/pubmed/30767788
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13104-019-4130-6
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak